Ubrelvy works by blocking calcitonin gene-related peptide (CGRP) receptors in your brain, which prevents CGRP from producing its effects. This helps reduce migraine symptoms. Most people experience ...

Ubrelvy (ubrogepant) and Nurtec ODT (rimegepant) are prescription drugs used to treat migraine episodes. Ubrelvy comes as a tablet that you swallow. Nurtec ODT comes as a tablet that dissolves on or ...

Ubrelvy is a prescription drug used to help treat migraine. It blocks a protein called calcitonin gene-related peptide (CGRP) from acting on your nervous system. Ubrelvy works rapidly, often in ...

For the roughly 40 million adults with migraine in the U.S., effective treatment is crucial; stopping an attack in its tracks can mean finishing the day instead of being stuck in bed. While triptans ...

Migraine isn’t simply a “bad headache” — it’s a complex neurological disease that can affect your entire brain and body before, during, and after the painful headache attack. Since 2018, several new ...

The approval of medicines called CGRP antagonists has led to big changes in how migraine is managed. These medicines work in a different way than older medicines to treat or prevent migraine. The ...

A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial has found. People who took ...

The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of ...

Ubrelvy (ubrogepant) is a brand-name prescription drug used to treat migraine episodes. It is a type of drug called a calcitonin gene-related peptide (CGRP) antagonist. If a person has a Medicare Part ...

Allergan’s Ubrelvy (ubrogepant) has won clearance in the US for the treatment of acute treatment of migraine in adults, with or without aura. The decision makes Ubrelvy the first oral CGRP receptor ...